CytoSorbents, the Nasdaq-listed healthcare company, has appointed Terri Anne Powers as vice president of investor relations and corporate communications, effective June 1.
Most recently, Powers served as vice president of IR at Diplomat Pharmacy, which was acquired by UnitedHealth Group last year for $300 mn. Prior to that, she worked for French company Veolia Environnement as its director of North American IR.
Powers began her career as a chemist and later worked as a sell-side analyst covering the healthcare industry for Prudential Securities and Robert W Baird. She holds an MBA from the University of Chicago Booth School of Business and the Investor Relations Charter credential, which is operated by NIRI.
‘We are delighted to welcome Terri Anne as vice president of IR and corporate communications, bringing this position in-house for the first time,’ says Dr Phillip Chan, CEO of CytoSorbents, in a statement.
‘Terri Anne has established a reputation in the healthcare industry as a smart, credible, articulate and responsive IR professional and analyst, with strong relationships [with] many major investors.’
In the statement, Powers adds: ‘I am thrilled to join CytoSorbents at such an exciting time and look forward to working with the leadership team and board of directors to increase the company’s visibility in the capital markets and broader stakeholder community.’
